The research community and pharmaceutical industry have made many life-saving and life-improving advances in global health over the past 20 years, and that’s certainly life-affirming news. But the time has come to ask ourselves a very pointed, and perhaps uncomfortable, question: “Are we defining ‘global health’ the right way?” And, more specifically, “How do we … Continue reading ““Global Health” Must Mean Global Health”
Author: Erik Iverson
Erik Iverson is the President, Business & Operations at IDRI. Prior to joining IDRI, Erik was Associate General Counsel at the Bill & Melinda Gates Foundation, where he was the second attorney on staff and worked for over seven years exclusively within the Foundation's Global Health Program, where he led the development and implementation of the foundation's Global Access policy through the review of grant proposals and assistance in structuring strategic initiatives. More particularly, Erik worked closely with foundation staff and grantees in the development of intellectual property management and collaboration agreements, novel financing arrangements, and product development and "global access" strategies. Previously, Erik was an attorney at the law firm of Perkins Coie LLP, where he represented life science companies in the negotiation of financing transactions, joint ventures, research collaborations, licensing arrangements, and manufacturing agreements. Erik received his JD from the University Of North Dakota School Of Law in 1994 and his Masters of Law (LLM) in Taxation from New York University School of Law in 1995.